the MedTech Exit Blueprint - Breakfast Panel

Thursday, May 28

8:00am – 10:00am

MTET

Hosted by

-‿-

:)

Building Access Instructions: Please check in with building security at the main desk in the lobby upon arrival. You will need to present a valid photo ID to register and receive elevator access to the 14th floor. We recommend arriving 10 minutes early to allow enough time for the security check-in process.

Join an exclusive gathering of growth-stage MedTech founders, executive teams, and visionary investors for a targeted deep dive into the strategic landscape of medical technology acquisitions. While clinical breakthroughs are the foundation, navigating the path to a successful exit requires a strategic blueprint. This breakfast panel will deconstruct the current environment, focusing on how growth-stage companies can strategically position themselves for acquisition and the technical, clinical, and financial milestones that define a successful exit in the market. Who should attend: Growth-stage MedTech founders, executive teams, investors, and family offices. Hosted By: - One Six 8 Ventures: An operator-led venture capital fund backing the next generation of disruptive MedTech companies. https://www.onesix8ventures.com - McCarter & English: A premier law firm providing legal counsel to life science companies throughout their entire growth lifecycle. https://www.mccarter.com/ Sponsors: Bene Studio: A digital product consultancy that designs, develops, and scales robust healthtech and MedTech solutions. https://benestudio.co/ The Consulate General of Canada in Boston supports Canadian companies through trade advocacy and international business development. https://www.international.gc.ca/country-pays/us-eu/boston.aspx This event is a part of #BOSTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com. Speakers Moderator: Min Lang, MD (Venture Partner, One Six 8 Ventures) Min Lang is a Venture Partner at One Six 8 Ventures and a board-certified neuroradiologist at Brigham and Women’s Hospital, holding an Assistant Professor appointment at Harvard Medical School. He leverages extensive clinical and entrepreneurial expertise to identify and scale high-impact MedTech and digital health solutions. Min is also a pioneer in medical extended reality, a startup founder, and actively advises early-stage life science companies. Ilana Lam Gotlib, Esq. (Founder, ILG Consulting LLC) Ilana Lam Gotlib assists medical device startups with fundraising strategies, corporate partnerships, and exit planning. She previously served as Senior Director of Strategy and Business Development for Stryker’s Digital, Robotics and Enabling Technologies division, following key roles at Philips and Johnson & Johnson. Ilana began her career as a medical malpractice litigation attorney, offering a unique perspective across healthcare law and corporate M&A. Jim Duronio (Sr. Director, Business Development, Hologic, Inc.) Jim Duronio leads M&A transactions, technical scouting, and early-stage innovation partnering for Hologic’s Surgical division. He has successfully executed multiple corporate acquisitions, including Acessa, Bolder Surgical, and Gynesonics. Prior to his business development career, Jim spent over 20 years in medical device product development specializing in minimally invasive gynecological surgical tools. Rahul Rakhit (Analyst, JJDC - Johnson & Johnson) Rahul Rakhit evaluates, sources, and supports early- and growth-stage medical technology investments for Johnson & Johnson's corporate venture capital arm. Before joining JJDC, he was a Senior Equity Research Analyst at LifeSci Capital covering small- and mid-cap MedTech and digital health companies. He holds an MS in Innovation and Management alongside a strong academic background in computational biology.

˜▾˜

*⏖*

❛ᴗ❛